Nextech Crossover I GP S.a r.l. 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:47 pm Purchase | 2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Nextech Crossover I GP S.a r.l. | 5,285,714 7.500% | 1,000,000 (+23.33%) | Filing |
| 2023-07-07 4:15 pm Purchase | 2023-06-27 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Nextech Crossover I GP S.a r.l. | 4,285,714 7.900% | 4,285,714 (New Position) | Filing |